Evidence map›Paper›PMID 38637663›Full record

ArticleScientific reports2024

A novel flexible exponent power-X family of distributions with applications to COVID-19 mortality rate in Mexico and Canada.

Zubir Shah, Dost Muhammad Khan, Imad Khan, Bakhtiyar Ahmad, Mouna Jeridi, Sanaa Al-Marzouki

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zubir ShahAbdul Wali Khan University Mardan, Mardan, Pakistan.
Dost Muhammad KhanAbdul Wali Khan University Mardan, Mardan, Pakistan.
Imad KhanAbdul Wali Khan University Mardan, Mardan, Pakistan.
Bakhtiyar AhmadHigher Education Department Afghanistan, Kart-e-Char, Afghanistan. mbakahmad82@gmail.com.
Mouna JeridiBiology Department, College of Science, King Khalid University, 61413, Abha, Saudi Arabia.
Sanaa Al-MarzoukiStatistics Department, Faculty of Science, King Abdul Aziz University Jeddah, Jeddah, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper aims to introduce a novel family of probability distributions by the well-known method of the T-X family of distributions. The proposed family is called a "Novel Generalized Exponent Power X Family" of distributions. A three-parameters special sub-model of the proposed method is derived and named a "Novel Generalized Exponent Power Weibull" distribution (NGEP-Wei for short). For the proposed family, some statistical properties are derived including the hazard rate function, moments, moment generating function, order statistics, residual life, and reverse residual life. The well-known method of estimation, the maximum likelihood estimation method is used for estimating the model parameters. Besides, a comprehensive Monte Carlo simulation study is conducted to assess the efficacy of this estimation method. Finally, the model selection criterion such as Akaike information criterion (AINC), the correct information criterion (CINC), the Bayesian information criterion (BINC), the Hannan-Quinn information criterion (HQINC), the Cramer-von-Misses (CRMI), and the ANDA (Anderson-Darling) are used for comparison purpose. The comparison of the NGEP-Wei with other rival distributions is made by Two COVID-19 data sets. In terms of performance, we show that the proposed method outperforms the other competing methods included in this study.

Indexed as

COVID-19Bayes TheoremCanadaComputer SimulationHumansMexicoCOVID-19 dataMaximum likelihood estimationMonte Carlo simulationNovel Generalized Exponent Power X familyWeibull distribution

Identifiers

PMID38637663
PMCPMC11026430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.